Global Choroidal Neovascularization Market By Product Type (Intravenous, Intravitreal) And By End-Users/Application (Extreme Myopia, Malignant Myopic Degeneration) Global Market Share, Forecast Data, In-Depth Analysis, And Detailed Overview, and Forecast, 2013 - 2026

According to Apex Market Research the Choroidal Neovascularization market was valued at USD xx.xx million in 2019 and is anticipated to grow at a CAGR of xx% during the forecast period from 2020 to 2028. The report on Choroidal Neovascularization market delivers detailed analysis covering major regional trends, market dynamics, and offer country-level market value of Choroidal Neovascularization industry. Some of the major aspects considered during the course of research comprises definition of the product, classification of the product, industry structure, different participants in the Choroidal Neovascularization ecosystem, etc. The report comprises of market value and forecast for the period from 2020 to 2028, CAGR measured for individual segment and regional market, competitive landscape of key market players, and profiling of major providers participating in the Choroidal Neovascularization market.

The following manufacturers are covered in this report:
  • Pfizer Inc.
  • F. Hoffmann-La Roche Ltd.
  • Novartis AG
  • Regeneron Pharmaceuticals Inc.
  • Bayer AG
  • QLT Inc.
  • Sanwa Kagaku Kenkyusho Co. Ltd.
  • Promedior Inc.
  • Bausch Health
  • Gilead Sciences Inc

The report estimates on the Choroidal Neovascularization market economy trend, market numbers (Mn/Bn USD) and CAGR from the 2020-2028, considering 2019 as the base year. A global Choroidal Neovascularization market report consist of all leading industry players, Choroidal Neovascularization business sections, company profile, revenue supply by Choroidal Neovascularization industry sections, global Choroidal Neovascularization market trends, acquisitions and arrangements, contact info, recent development, geographic examination and even more using the assistance.

Since the onset of COVID-19 in December 2019, the governments of various countries declared lockdown and as result numerous economies around the world experienced severe economic downturn. Since early 2020, the Choroidal Neovascularization market witnessed the impact of COVID-19 The report objects to provide pre-COVID-19 state of the Choroidal Neovascularization market in years 2020 and 2019 and moreover it offers forecast for the Covid-19 period from 2020 to 2028.The report provides COVID-19 impact on Choroidal Neovascularization market, global analysis, different challenges or threats and opportunities for stakeholders involved in the Choroidal Neovascularization market.

Report Opportunity: Global Choroidal Neovascularization Market

This report delivers an analytical examination of the Choroidal Neovascularization market summarized in broad sections such as
  1. Choroidal Neovascularization Market Summary
  2. Key Commercial Growths in the Choroidal Neovascularization Industry
  3. Market Dynamics Affecting the Choroidal Neovascularization Industry
  4. Important Market Trends and Future Development Scenario of the Choroidal Neovascularization Market
  5. Choroidal Neovascularization Market Revenue and Forecast, by Type, 2018 – 2028
  6. Competitive Landscape of Choroidal Neovascularization Industry
  7. Positioning of Main Market Players in the Choroidal Neovascularization Industry
  8. Choroidal Neovascularization Market Revenue and Forecast, by Application, 2018 - 2028
  9. Choroidal Neovascularization Market Revenue and Forecast, by End-use, 2018 - 2028
  10. Choroidal Neovascularization Market Revenue and Forecast, by Geography, 2018 - 2028
Choroidal Neovascularization Market Segmentation:

The report provides detailed examination of the Choroidal Neovascularization market on the basis of various segments such as type, application and end-use industry. The Choroidal Neovascularization market is segmented as follows:

Choroidal Neovascularization Market, by Type:
  • Intravenous
  • Intravitreal
Choroidal Neovascularization Market, by Application:
  • Extreme Myopia
  • Malignant Myopic Degeneration
  • Age-Related Developments
Geographic Coverage

The report on the Choroidal Neovascularization market delivers an in depth country-level cross-sectional analysis across different regions around the globe. The report comprises of complete market value and forecast for the following countries and regions:

North America Choroidal Neovascularization Market Revenue and Forecast
  • U.S.
  • Canada
Europe Choroidal Neovascularization Market Revenue and Forecast
  • UK
  • Germany
  • France
  • Rest of Europe
Asia Pacific Choroidal Neovascularization Market Revenue and Forecast
  • China
  • Japan
  • India
  • Rest of Asia Pacific
Latin America Choroidal Neovascularization Market Revenue and Forecast
  • Mexico
  • Brazil
  • Rest of Latin America
Middle East and Africa Choroidal Neovascularization Market Revenue and Forecast
  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa
1. Preface
     1.1. Report Scope and Description
     1.2. Research Methodology
          1.2.1. Phase I-Secondary Research
          1.2.2. Phase II-Primary Research
          1.2.3. Phase II-Expert Panel Review
          1.2.4. Assumptions
          1.2.5. Approach Adopted

2. Executive Summary
     2.1. Global Choroidal Neovascularization Market Snapshot
          2.1.1. Global Choroidal Neovascularization Market By Type,2019
               2.1.1.1.Intravenous
               2.1.1.2.Intravitreal
          2.1.2. Global Choroidal Neovascularization Market By Application,2019
               2.1.2.1.Extreme Myopia
               2.1.2.2.Malignant Myopic Degeneration
               2.1.2.3.Age-Related Developments
          2.1.3. Global Choroidal Neovascularization Market By End-use,2019
          2.1.4. Global Choroidal Neovascularization Market By Geography,2019

3. Global Choroidal Neovascularization Market Dynamics
     3.1. Market Overview
     3.2. Market Inclination Insights Analysis
     3.3. Drivers
     3.4. Challenges
     3.5. Future Prospects
     3.6. Impact Analysis of Drivers and Challenges During the Forecast Period, (2020-2028)

4. Global Choroidal Neovascularization Market Size (US$), By Type, 2018 – 2028 
     4.1. Overview
          4.1.1. Market Share Analysis By Type, 2019 vs.2028
          4.1.2. Attractive Investment Proposition By Type, 2020
     4.2. Global Choroidal Neovascularization Market Size (US$), By Type, 2018 – 2028

5. Global Choroidal Neovascularization Market Size (US$), By Application, 2018 – 2028 
     5.1. Overview
          5.1.1. Market Share Analysis By Application, 2019 vs.2028
          5.1.2. Attractive Investment Proposition By Application, 2020
     5.2. Global Choroidal Neovascularization Market Size (US$), By Application, 2018 – 2028

6. Global Choroidal Neovascularization Market Size (US$), By End-use, 2018 – 2028 
     6.1. Overview
          6.1.1. Market Share Analysis By End-use, 2019 vs.2028
          6.1.2. Attractive Investment Proposition By End-use, 2020
     6.2. Global Choroidal Neovascularization Market Size (US$), By End-use, 2018 – 2028

7. Global Choroidal Neovascularization Market Size (US$), By Geography, 2018 – 2028
     7.1. Overview
          7.1.1. Market Share Analysis by Geography, 2019 vs. 2028
          7.1.2. Attractive Investment Proposition by Geography, 2020
     7.2. North America Choroidal Neovascularization Market Analysis, 2018 – 2028 
          7.2.1. North America Choroidal Neovascularization Market Size (US$), By Country, 2018 – 2028 
               7.2.1.1. U.S.
               7.2.1.2. Canada
          7.2.2. North America Choroidal Neovascularization Market Size (US$), By Type, 2018 – 2028
          7.2.3. North America Choroidal Neovascularization Market Size (US$), By Application, 2018 – 2028
          7.2.4. North America Choroidal Neovascularization Market Size (US$), By End-use, 2018 – 2028
     7.3. Europe Choroidal Neovascularization Market Analysis, 2018 – 2028 
          7.3.1.  Europe Choroidal Neovascularization Market Size (US$), By Country, 2018 – 2028 
               7.3.1.1. U.K.
               7.3.1.2. Germany
               7.3.1.3. France
               7.3.1.4. Rest of Europe
          7.3.2. Europe Choroidal Neovascularization Market Size (US$), By Type, 2018 – 2028
          7.3.3. Europe Choroidal Neovascularization Market Size (US$), By Application, 2018 – 2028
          7.3.4. Europe Choroidal Neovascularization Market Size (US$), By End-use, 2018 – 2028
     7.4. Asia Pacific Choroidal Neovascularization Market Analysis , 2018 – 2028
          7.4.1.  Asia Pacific Choroidal Neovascularization Market Size (US$), By Country, 2018 – 2028 
               7.4.1.1. China
               7.4.1.2. Japan
               7.4.1.3. India
               7.4.1.4. Rest of Asia Pacific
          7.4.2. Asia Pacific Choroidal Neovascularization Market Size (US$), By Type, 2018 – 2028
          7.4.3. Asia Pacific Choroidal Neovascularization Market Size (US$), By Application, 2018 – 2028
          7.4.4. Asia Pacific Choroidal Neovascularization Market Size (US$), By End-use, 2018 – 2028
     7.5. Latin America Choroidal Neovascularization Market Analysis, 2018 – 2028 
          7.5.1.  Latin America Choroidal Neovascularization Market Size (US$), By Country, 2018 – 2028 
               7.5.1.1. Brazil
               7.5.1.2. Mexico
               7.5.1.3. Rest of Latin America
          7.5.2. Latin America Choroidal Neovascularization Market Size (US$), By Type, 2018 – 2028
          7.5.3. Latin America Choroidal Neovascularization Market Size (US$), By Application, 2018 – 2028
          7.5.4. Latin America Choroidal Neovascularization Market Size (US$), By End-use, 2018 – 2028
     7.6. Middle East & Africa (MEA) Choroidal Neovascularization Market Analysis, 2018 – 2028 
          7.6.1.  MEA Choroidal Neovascularization Market Size (US$), By Region, 2018 – 2028 
               7.6.1.1. GCC Countries
               7.6.1.2. South Africa
               7.6.1.3. Rest of MEA
          7.6.2. MEA Choroidal Neovascularization Market Size (US$), By Type, 2018 – 2028
          7.6.3. MEA Choroidal Neovascularization Market Size (US$), By Application, 2018 – 2028
          7.6.4. MEA Choroidal Neovascularization Market Size (US$), By End-use, 2018 – 2028

8. Company Profiles
     8.1. Competitive Analysis 
     8.2. Market Positioning of Key Vendors 
     8.3. Key Strategies adopted by the Leading Players
     8.4. Key Choroidal Neovascularization Providers
        8.4.1 Pfizer Inc.
                8.1.1 Business Description
                8.1.2 Pfizer Inc. Geographic Operations
                8.1.3 Pfizer Inc. Financial Information
                8.1.4 Pfizer Inc. Product Positions/Portfolio
                8.1.5 Pfizer Inc. Key Developments
        8.4.2 F. Hoffmann-La Roche Ltd.
                8.2.1 Business Description
                8.2.2 F. Hoffmann-La Roche Ltd. Geographic Operations
                8.2.3 F. Hoffmann-La Roche Ltd. Financial Information
                8.2.4 F. Hoffmann-La Roche Ltd. Product Positions/Portfolio
                8.2.5 F. Hoffmann-La Roche Ltd. Key Developments
        8.4.3 Novartis AG
                8.3.1 Business Description
                8.3.2 Novartis AG Geographic Operations
                8.3.3 Novartis AG Financial Information
                8.3.4 Novartis AG Product Positions/Portfolio
                8.3.5 Novartis AG Key Developments
        8.4.4 Regeneron Pharmaceuticals Inc.
                8.4.1 Business Description
                8.4.2 Regeneron Pharmaceuticals Inc. Geographic Operations
                8.4.3 Regeneron Pharmaceuticals Inc. Financial Information
                8.4.4 Regeneron Pharmaceuticals Inc. Product Positions/Portfolio
                8.4.5 Regeneron Pharmaceuticals Inc. Key Developments
        8.4.5 Bayer AG
                8.5.1 Business Description
                8.5.2 Bayer AG Geographic Operations
                8.5.3 Bayer AG Financial Information
                8.5.4 Bayer AG Product Positions/Portfolio
                8.5.5 Bayer AG Key Developments
        8.4.6 QLT Inc.
                8.6.1 Business Description
                8.6.2 QLT Inc. Geographic Operations
                8.6.3 QLT Inc. Financial Information
                8.6.4 QLT Inc. Product Positions/Portfolio
                8.6.5 QLT Inc. Key Developments
        8.4.7 Sanwa Kagaku Kenkyusho Co. Ltd.
                8.7.1 Business Description
                8.7.2 Sanwa Kagaku Kenkyusho Co. Ltd. Geographic Operations
                8.7.3 Sanwa Kagaku Kenkyusho Co. Ltd. Financial Information
                8.7.4 Sanwa Kagaku Kenkyusho Co. Ltd. Product Positions/Portfolio
                8.7.5 Sanwa Kagaku Kenkyusho Co. Ltd. Key Developments
        8.4.8 Promedior Inc.
                8.8.1 Business Description
                8.8.2 Promedior Inc. Geographic Operations
                8.8.3 Promedior Inc. Financial Information
                8.8.4 Promedior Inc. Product Positions/Portfolio
                8.8.5 Promedior Inc. Key Developments
        8.4.9 Bausch Health
                8.9.1 Business Description
                8.9.2 Bausch Health Geographic Operations
                8.9.3 Bausch Health Financial Information
                8.9.4 Bausch Health Product Positions/Portfolio
                8.9.5 Bausch Health Key Developments
        8.4.10 Gilead Sciences Inc
                8.10.1 Business Description
                8.10.2 Gilead Sciences Inc Geographic Operations
                8.10.3 Gilead Sciences Inc Financial Information
                8.10.4 Gilead Sciences Inc Product Positions/Portfolio
                8.10.5 Gilead Sciences Inc Key Developments

LIST OF TABLES

TABLE 1 Market Snapshot: Global Choroidal Neovascularization Market 
TABLE 2 Impact Indicators 
TABLE 3 Impact Analysis of Drivers and Restraints 
TABLE 4 North America Choroidal Neovascularization Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 5 North America Choroidal Neovascularization Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 6 North America Choroidal Neovascularization Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 7 Europe Choroidal Neovascularization Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 8 Europe Choroidal Neovascularization Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 9 Europe Choroidal Neovascularization Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 10 Asia Pacific Choroidal Neovascularization Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 11 Asia Pacific Choroidal Neovascularization Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 12 Asia Pacific Choroidal Neovascularization Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 13 Latin America Choroidal Neovascularization Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 14 Latin America Choroidal Neovascularization Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 15 Latin America Choroidal Neovascularization Market Revenue, By End-use, 2018 – 2028 (US$ Mn)
TABLE 16 MEA Choroidal Neovascularization Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 17 MEA Choroidal Neovascularization Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 18 MEA Choroidal Neovascularization Market Revenue, By End-use, 2018 – 2028 (US$ Mn)

LIST OF FIGURES

FIG. 1 Global Choroidal Neovascularization: Market Segmentation 
FIG. 2 Global Choroidal Neovascularization Market: Research Methodology 
FIG. 3 Top-Down and Bottom-up Approach 
FIG. 4 Global Choroidal Neovascularization Market, By Type, 2019 (US$ Mn) 
FIG. 5 Global Choroidal Neovascularization Market, By Application, 2019 (US$ Mn) 
FIG. 6 Global Choroidal Neovascularization Market, By End-use, 2019 (US$ Mn) 
FIG. 7 Global Choroidal Neovascularization Market, By Geography, 2019 (US$ Mn) 
FIG. 8 Global Choroidal Neovascularization Market Revenue and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG. 9 Attractive Investment Proposition 
FIG. 10 Market Positioning of Key Choroidal Neovascularization Providers, 2019
FIG. 11 Global Choroidal Neovascularization Market Revenue Contribution, By Type, 2019 & 2028 (Value %) 
FIG. 12 Global Choroidal Neovascularization Market Revenue Contribution, By Application, 2019 & 2028 (Value %) 
FIG. 13 Global Choroidal Neovascularization Market Revenue Contribution, By End-use, 2019 & 2028 (Value %) 
FIG. 14 North America Choroidal Neovascularization Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 15 Europe Choroidal Neovascularization Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 16 Asia Pacific Choroidal Neovascularization Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 17 Latin America Choroidal Neovascularization Market Revenue, 2018 – 2028, (US$ Mn)
FIG. 18 MEA Choroidal Neovascularization Market Revenue, 2018 – 2028, (US$ Mn)

Key Takeaways:

1. Market value and estimate of the Choroidal Neovascularization market for the period from 2020 to 2028
2. Compounded annual growth rate (CAGR%) for individual segments in various regional markets for a period from 2020 to 2028
3. Value chain analysis
4. Market share study combined with competitive landscape of major players
5. Profiles of major market players covering overall business operations, geographic occurrence, product portfolio, financial status and news coverage 
1706

1607

OUR CLIENT